FDA approves Pfenex's osteoporosis therapy
October 07, 2019 at 06:00 AM EDT
The U.S. Food and Drug Administration on Monday approved a bone-building drug from Pfenex Inc to treat osteoporosis in certain patients at high risk for fractures, giving the company its first commercial product.
